Induced Vitiligo due to Talimogene Laherparepvec Injection for Metastatic Melanoma Associated with Long-term Complete Response

Acta Derm Venereol. 2019 Feb 1;99(2):232-233. doi: 10.2340/00015555-3061.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Biological Products / adverse effects*
  • Female
  • Herpesvirus 1, Human
  • Humans
  • Male
  • Melanoma / secondary
  • Melanoma / therapy*
  • Melanoma / virology
  • Middle Aged
  • Oncolytic Virotherapy / adverse effects*
  • Remission Induction
  • Skin / physiopathology
  • Skin / virology*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy*
  • Skin Neoplasms / virology
  • Skin Pigmentation*
  • Time Factors
  • Treatment Outcome
  • Vitiligo / diagnosis
  • Vitiligo / physiopathology
  • Vitiligo / virology*

Substances

  • Biological Products
  • talimogene laherparepvec